ACHE and Alzheimer disease: We would also like to explore novel heterocyclic scaffold in order to verify if this combination of activities is transposable to novel chemical series that could combine a symptomatic action (restoration of the cholinergic activity) and a disease-modifying effect (promotion of sAPPα, inhibition of the AChE-induced Aβ aggregation) that seems to be a relevant approach to treat AD.